Re: Clinical and Immunological Characteristics of Patients With Serologic Progression of Prostate Cancer Achieving Long-Term Disease Control With Granulocyte-Macrophage Colony-Stimulating Factor. B. I. Rini, L. Fong, V. Weinberg, B. Kavanaugh and E. J. Small J Urol 2006; 175: 2087-2091 | Documentos